SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

L3Harris Technologies, Inc. engages in the provision of defense and commercial technologies across the air, land, sea, space, and cyber domains. It operates through the following segments: Communication Systems, Integrated Mission Systems, Space and Airborne Systems, and Aerojet Rocketdyne. The Communication Systems segment enables warfighters across all domains with solutions critical to mission success even in the most contested environments. The Integrated Mission Systems segment focuses on the differentiated mission capabilities and prime systems integration for the air, land, and sea domains. The Space and Airborne Systems segment provides full mission solutions as a prime and subsystem integrator in the space, airborne, and cyber domains. The Aerojet Rocketdyne segment includes propulsion, power and armament products and systems to U.S. government, including the DoD, National Aeronautics and Space Administration (“NASA”) and major aerospace and defense prime contractors. The company was founded in 1890 and is headquartered in Melbourne, FL.

L3Harris Technologies Inc

L3Harris is trending following a $1 billion Pentagon investment in its missile business and an announced plan to spin off the unit as a standalone, publicly traded company in late 2026. While some investors view the spinoff as a strategic way to unlock value and scale manufacturing, the stock is seeing significant volatility as traders debate the long-term impact on the core business and current valuation.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

The community discussion is fragmented, characterized by a mix of political commentary regarding the upcoming election cycle, speculation on geopolitical tensions in the Middle East, and varied technical analysis of broader market direction and inflation concerns.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

AbbVie is trending following reports that it is nearing a multi-billion dollar deal to acquire Apogee Therapeutics, a move aimed at bolstering its immunology pipeline and offsetting patent expirations. Additionally, the company remains a focus for traders monitoring its ongoing dividend payments and performance relative to other major healthcare stocks.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZeneca's stock is experiencing pressure after a late-stage clinical trial for its heart disease drug, Wainua, failed to meet its primary endpoint, leading to concerns about the company's future revenue potential. Traders are debating the significance of the trial miss against the firm's broader oncology pipeline, with some viewing the decline as an opportunity to buy the dip while others remain cautious regarding management's credibility.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgen is trending due to a sympathy sell-off following the failure of Novartis's cholesterol drug pelacarsen to meet its primary endpoint in a late-stage clinical trial. While some analysts have downgraded the stock citing valuation and 'read-through' risk to Amgen's own candidate, olpasiran, many traders and market commentators argue the reaction is an overblown emotional response to sector-wide pipeline risk.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

ON Semiconductor is trending as traders analyze the impact of the company's $7 billion all-stock acquisition of Synaptics, with sentiment split between concerns over equity dilution and optimism regarding long-term expansion into physical AI and edge computing. While the stock faced sharp selling pressure following the announcement, some investors view the pullback as a potential entry point for long-term growth.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include core, cognitive adjacencies, and cognitive networks. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Arista Networks is trending as investors exhibit strong confidence in the company's role as a critical networking infrastructure provider for AI data centers and hyperscaler cloud expansion. The stock is receiving attention due to its sustained technical momentum and positioning as a beneficiary of robust AI-related capital expenditure.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is trending as investors debate whether recent infrastructure developments and acquisition plans signal long-term adoption or represent a recurring pump-and-dump scheme. While some traders point to potential institutional partnerships and ecosystem growth as bullish catalysts, others argue the asset is failing to hold gains and remains speculative.

Frequency Electronics, Inc. engages in the design, development, and manufacture of precision time and frequency generation technology. It operates through the following business segments: FEI-NY and FEI-Zyfer. The FEI-NY segment provides precision time, frequency generation, and synchronization products and subsystems that are found on-board satellites, in ground-based communication stations, and imbedded in moving platforms. The FEI-Zyfer segment designs, develops, and manufactures products for precision time and frequency generation and synchronization, primarily incorporating GPS technology. The company was founded by Martin B. Bloch on August 25, 1961 and is headquartered in Uniondale, NY.

Frequency Electronics, Inc.

Frequency Electronics is trending following strong interest in its role within the "Golden Dome" missile defense system and its advancements in quantum sensing technology. The community is largely bullish, highlighting the company's low float, institutional backing, and expectations for major defense contract wins.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

Gilead Sciences is trending as traders speculate on potential acquisition targets within the biotech sector, specifically monitoring its ongoing interest in oncology and immunology-focused companies like Kyverna Therapeutics. Additionally, community discussion is bolstered by interest in the company's research expansion and clinical development pipeline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

General Fusion Provides First Public Company Business Update

Entered the Public Markets with ~US$150 Million in Cash to Advance Fusion Development and Demonstrate Commercially Relevant Magnetized Target Fusion Capabilities
VANCOUVER, British Columbia, Aug.  18, 2026 (GLOBE NEWSWIRE) -- General Fusion Group Ltd. (NASDAQ: GFUZ) (“General Fusion” or the “Company”), a leader in the global race to commercialize fusion energy, will provide a business update today and highlight recent progress across its technology and commercial initiatives. General Fusion became the first publicly listed fusion company following its July 2026 listing on Nasdaq under the ticker symbol “GFUZ.”
  
Operational Highlights
  
Financial Position: Following completion of its business combination with Spring Valley Acquisition Corp. III, General Fusion entered the public markets with approximately US$150 million in cash, inclusive of net transaction proceeds from the private placement and trust capital, to advance its practical fusion energy technology. The Company expects this capital to fund its Lawson Machine 26 (“LM26”) program across several planned technical milestones through the end of 2028.
Technology: General Fusion recently announced significant progress toward its next major technical milestone with the LM26 program. The Company successfully demonstrated plasma heating to approximately 0.72 keV (8.4 million degrees Celsius) using compression of a plasma with a lithium liner, representing important progress toward its near-term objective of achieving 1 keV, followed by 10 keV and ultimately the Lawson criterion, the combination of plasma parameters that can produce net fusion energy in the plasma. 
Commercial: General Fusion announced a milestone-based framework agreement with Renexia S.p.A., a Toto Group company, to collaborate on the potential commercial deployment of the Company’s fusion energy technology in Italy. This agreement represents another step in expanding relationships ahead of future commercialization.
Strategic Partnerships: General Fusion expanded its technology ecosystem through a collaboration with General Atomics Energy Group to advance plasma diagnostics capable of measuring temperatures exceeding 10 keV, equivalent to approximately 100 million degrees Celsius, during the second phase of the LM26 program.

  
“Our listing on Nasdaq marks an important milestone for General Fusion and the broader fusion industry,” said Greg Twinney, Chief Executive Officer of General Fusion. “We believe fusion is approaching an important inflection point. Decades of advances in plasma physics, high-performance computing, advanced manufacturing, and digital controls have converged with rapidly growing global demand for clean, reliable baseload power, creating the conditions for fusion to transition from scientific promise toward commercial reality.”
  
Twinney continued, “General Fusion was built for this moment. Our Magnetized Target Fusion approach is designed to deliver practical, clean, and abundant fusion energy through a simpler machine architecture that leverages existing industrial materials and supply chains while avoiding many of the cost and complexity challenges relied upon by other fusion technologies. Over more than two decades, we have systematically advanced that approach through real-world testing on increasingly sophisticated demonstration systems and published peer-reviewed scientific results. We believe this disciplined, engineering-driven strategy positions us to reduce technical risk while advancing toward the commercialization of practical fusion energy.”
  
Twinney added, “We recently announced meaningful progress toward our next major technical milestone with LM26, expanded our commercial ecosystem through our framework agreement with Renexia, strengthened our technology partnerships via our collaboration with General Atomics, and entered the public markets with approximately US$150 million to fund our LM26 program through several key technical milestones by the end of 2028.”
  
Twinney concluded, “We believe the industry’s next chapter will be defined by disciplined technical and commercial execution. Our priorities are clear: continue achieving measurable technical milestones, expand our commercial partnerships, strengthen our supply chain capabilities, and build the foundation for the deployment of our first-of-a-kind fusion plant by approximately 2035. We look forward to demonstrating our progress to shareholders as we execute against that roadmap.”
  
Looking Ahead
General Fusion remains focused on executing its staged commercialization roadmap. Near-term priorities include:
  
Achieve the 1 keV plasma electron temperature milestone.
Advance toward 10 keV and ultimately the Lawson criterion, supporting the Company’s objective of demonstrating commercially relevant fusion conditions.
Expand commercial, supply chain development, and strategic partnerships across energy, industrial, engineering, and technology ecosystems.
Enable the successful siting of future demonstration and commercial-scale fusion energy systems that support technical success, commercial growth, and long-term scalability.

  
Webcast
A live webcast of the call can be accessed by visiting the Events & Presentations page of General Fusion’s investor relations website. Participants who wish to join by phone and ask questions during the Q&A may register here to receive dial-in details and a unique PIN.
  
A replay of the webcast will be available for 12 months on the Events & Presentations page of General Fusion’s investor relations website.
  
About General Fusion
General Fusion (NASDAQ: GFUZ) is pursuing a practical approach to commercial fusion energy and is headquartered in Vancouver, Canada. The Company was established in 2002 and has been funded by global investors including leading energy venture capital firms, industry leaders, and technology pioneers. Learn more at www.generalfusion.com.
  
Cautionary Note Regarding Forward-Looking Statements
Certain statements included in this news release are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this news release are forward-looking statements. Any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are also forward-looking statements. In some cases, you can identify forward-looking statements by words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “expect,” “anticipate,” “believe,” “seek,” “strategy,” “future,” “opportunity,” “may,” “target,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” “preliminary,” or similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements include, without limitation, statements regarding the significance of prior technical results including plasma heating to approximately 0.72 keV (8.4 million degrees Celsius), the possibility that the Company will achieve its targeted milestones, including 1 keV plasma electron heating; its ability to commercialize Magnetized Target Fusion (“MTF”) or any other fusion technology on its expected timeline or at all; and statements regarding the current and expected results of the LM26 program; as well as any information concerning possible or assumed future results of operations or financial position of the Company.
  
These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions, many of which are beyond the control of the Company. These forward-looking statements involve a number of risks, uncertainties, or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, the risk that the Company is unable to maintain the listing of its securities on Nasdaq; the risk that the price of the Company’s securities may be volatile due to a variety of factors outside of the Company’s control, the risk that the Company never generates revenue, the risk that the Company fails to commercialize MTF on a cost effective basis, on the expected timeline or at all, the risk that the Company fails to achieve the objectives of the LM26 program, the risk that the technical results disclosed herein are not accepted or validated by the scientific community; the risk that prior results are not successfully repeated on a larger scale; the risk that the scientific and technical assumptions underlying the results described herein prove to be incorrect; the risk that recent technical results do not prove to be as significant to the operation of LM26 as expected; the risk that the anticipated cost of funding the LM26 program across several planned technical milestones through the end of 2028 is greater than anticipated and additional capital needed by the Company may not be raised on favorable terms, or at all, including as a result of the restrictions agreed to in connection with the private placement the Company closed on July 10, 2026; the risk that the Company and Renexia are unable to agree on the terms of a definitive agreement, the risk that the Company’s collaboration with the General Atomics Group is terminated, the risk that fusion energy does not gain public acceptance, the risk that the scientific and technical assumptions upon which MTF technology is based do not prove to be correct, the risk that our competitors develop viable fusion technology sooner than we do, the risk of supply chain disruptions, the risk that key technical material and service inputs may not be available when required on reasonable terms or at all, the risk that we are unable to attract and retain qualified personnel with highly technical expertise, the risk that we are subject to negative publicity, the risk that our assessment of the total addressable market for fusion energy is incorrect, the risk of changes in the laws and regulations governing the Company’s research and development activities and in the regulation of fusion energy; the risk of fluctuations in currency markets; the risk that the Company is unable to complete and successfully integrate any future acquisitions; the risk of increased competition in the fusion industry; the risk of accidents, earthquake, fires, floods and other natural disasters, the risk that our information technology fails, the risk that our operating expenses are materially higher than forecast, the risk that we are unable to remediate material weaknesses in our internal controls or identify additional material weaknesses in the future, the risk that we are unable to adequately protect or enforce our intellectual property rights, the risk of third party claims that we are infringing or violating another person’s intellectual property rights, the risk that our intellectual property applications are not granted, the risk of a cyber event or privacy breach resulting in an interruption in operations or financial loss, the risk that government reduces or delays funding of government programs in which we participate, the risk that future sales by existing shareholders could cause our stock price to decline, and the risk that we are unable to establish and maintain effective internal controls to produce accurate and timely public disclosure.
  
These forward-looking statements are based on certain assumptions, including that none of the risks identified above materialize; that there are no unforeseen changes to economic and market conditions, and that no significant events occur outside the ordinary course of business.
  
The foregoing list is not exhaustive, and there may be additional risks that the Company does not know or currently believes are immaterial. You should carefully consider the foregoing factors, any other factors discussed herein and in the other filings by the Company with the U.S. Securities and Exchange Commission including those described under the heading “Risk Factors.” The Company does not undertake to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required in accordance with applicable laws.
  
Investor Relations Contact:
You can contact General Fusion’s Investor Relations team by email at: investors@generalfusion.com.
  
If you are based in North America, you may also leave a toll-free voicemail at +1 (833) 717-1519. Callers outside North America can reach us at +1 (236) 253-6968. 
  
Media Relations Contact:
media@generalfusion.com
1-866-904-0995

General Fusion to Host Business Update Conference Call on August 18, 2026

VANCOUVER, British Columbia, Aug.  06, 2026  (GLOBE NEWSWIRE) -- General Fusion Group Ltd. (“General Fusion” or the “Company”) (NASDAQ: GFUZ), a leader in the global race to commercialize fusion energy, today announced it will host a conference call to provide a business update at 4:30 p.m. Eastern Time on Tuesday, August 18, 2026.
  
A live webcast of the call can be accessed by visiting the Events & Presentations page of General Fusion’s investor relations website. Participants who wish to join by phone and ask questions during the Q&A may register here to receive dial-in details and a unique PIN.
  
A replay of the webcast will be available for 12 months on the Events & Presentations page of General Fusion’s investor relations website.
  
About General Fusion 
  
General Fusion (NASDAQ: GFUZ) is pursuing a practical approach to commercial fusion energy and is headquartered in Vancouver, Canada. The Company was established in 2002 and has been funded by global investors including leading energy venture capital firms, industry leaders, and technology pioneers. Learn more at www.generalfusion.com.
  
Cautionary Note Regarding Forward-Looking Statements 
  
Certain statements included in this news release are not historical facts but are forward-looking statements within the meaning of the U.S. federal securities laws and “forward-looking information” within the meaning of applicable Canadian securities laws (collectively, “forward-looking statements”). All statements other than statements of historical fact contained in this news release are forward-looking statements. Any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are also forward-looking statements. In some cases, you can identify forward-looking statements by words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “expect,” “anticipate,” “believe,” “seek,” “strategy,” “future,” “opportunity,” “may,” “target,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” “preliminary,” or similar expressions that predict or indicate future events or trends or that are not statements of historical matters. However, the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements include, without limitation, statements regarding the outlook for the business of General Fusion, including its ability to commercialize MTF or any other fusion technology on its expected timeline or at all; and any information concerning the possible or assumed future results of operations or financial position of the Company. 
  
These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied upon as, a guarantee, assurance, prediction, or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions, many of which are beyond the control of the Company. These forward-looking statements involve a number of risks, uncertainties, or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to: the risk that the Company is unable to maintain the listing of its securities on Nasdaq; the risk that the price of the Company’s securities may be volatile due to a variety of factors outside of the Company’s control; the risk that the Company never generates revenue; the risk that the Company fails to commercialize MTF on a cost-effective basis, on the expected timeline, or at all; the risk that the Company fails to achieve the objectives of the LM26 program; the risk that additional capital needed by the Company may not be raised on favorable terms, or at all, including as a result of the restrictions agreed to in connection with the private placement the Company closed on July 10, 2026; the risk that fusion energy does not gain public acceptance; the risk that the scientific and technical assumptions upon which MTF technology is based do not prove to be correct; the risk that our competitors develop viable fusion technology sooner than we do; the risk of supply chain disruptions; the risk that key technical material and service inputs may not be available when required, on reasonable terms or at all; the risk that we are unable to attract and retain qualified personnel with highly technical expertise; the risk that we are subject to negative publicity; the risk that our assessment of the total addressable market for fusion energy is incorrect; the risk of changes in the laws and regulations governing the Company’s research and development activities and in the regulation of fusion energy; the risk of fluctuations in currency markets; the risk that the Company is unable to complete and successfully integrate any future acquisitions; the risk of increased competition in the fusion industry; the risk of accidents, earthquakes, fires, floods, and other natural disasters; the risk that our information technology fails; the risk that our operating expenses are materially higher than forecast; the risk that we are unable to remediate material weaknesses in our internal controls or identify additional material weaknesses in the future; the risk that we are unable to adequately protect or enforce our intellectual property rights; the risk of third-party claims that we are infringing or violating another person’s intellectual property rights; the risk that our intellectual property applications are not granted; the risk of a cyber event or privacy breach resulting in an interruption in operations or financial loss; the risk that government reduces or delays funding of government programs in which we participate; the risk that future sales by existing shareholders could cause our stock price to decline; and the risk that we are unable to establish and maintain effective internal controls to produce accurate and timely public disclosure. 
  
These forward-looking statements are based on certain assumptions, including that none of the risks identified above materialize, that there are no unforeseen changes to economic and market conditions, and that no significant events occur outside the ordinary course of business. 
  
The foregoing list is not exhaustive, and there may be additional risks that the Company does not know or currently believes are immaterial. You should carefully consider the foregoing factors, any other factors discussed herein, and in the other filings by the Company with the U.S. Securities and Exchange Commission, including those described under the heading “Risk Factors.” The Company does not undertake to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required in accordance with applicable laws.
  
Investor Relations Contact:
You can contact General Fusion’s Investor Relations team by email at: investors@generalfusion.com.
  
If you are based in North America, you may also leave a toll-free voicemail at +1 (833) 717-1519. Callers outside North America can reach us at +1 (236) 253-6968. 
  
Media Relations Contact:
media@generalfusion.com
1-866-904-0995

General Fusion to Participate in Canaccord Genuity Growth Conference

Others

VANCOUVER, British Columbia, July  30, 2026  (GLOBE NEWSWIRE) -- General Fusion Group Ltd. (“General Fusion” or the “Company”) (NASDAQ: GFUZ), a leader in the global race to commercialize fusion energy, today announced that members of its leadership team will participate in Canaccord Genuity’s 46th Annual Growth Conference in Boston.
  
Chief Strategy Officer Megan Wilson is scheduled to participate in a fireside chat on August 11 at 12:30 p.m. ET. To register for the webcast, please visit www.event.summitcast.com.
  
A replay of the fireside chat will be available on the Events & Presentations page of General Fusion’s investor relations website.
  
To arrange a one-on-one meeting with General Fusion during the conference, please contact your Canaccord Genuity representative or email investors@generalfusion.com.
  
About General Fusion 
  
General Fusion (NASDAQ: GFUZ), the first publicly listed fusion energy company, is headquartered in Vancouver, Canada, and is pursuing a practical approach to commercial fusion energy. Founded in 2002, the Company has received funding from global investors, including leading energy venture capital firms, industry leaders, and technology pioneers. Learn more at www.generalfusion.com.
  
Cautionary Note Regarding Forward-Looking Statements 
  
Certain statements included in this news release are not historical facts but are forward-looking statements within the meaning of the U.S. federal securities laws and “forward-looking information” within the meaning of applicable Canadian securities laws (collectively, “forward-looking statements”). All statements other than statements of historical fact contained in this news release are forward-looking statements. Any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are also forward-looking statements. In some cases, you can identify forward-looking statements by words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “expect,” “anticipate,” “believe,” “seek,” “strategy,” “future,” “opportunity,” “may,” “target,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” “preliminary,” or similar expressions that predict or indicate future events or trends or that are not statements of historical matters. However, the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements include, without limitation, statements regarding the outlook for the business of General Fusion, including its ability to commercialize MTF or any other fusion technology on its expected timeline or at all; and any information concerning the possible or assumed future results of operations or financial position of the Company. 
  
These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied upon as, a guarantee, assurance, prediction, or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions, many of which are beyond the control of the Company. These forward-looking statements involve a number of risks, uncertainties, or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to: the risk that the Company is unable to maintain the listing of its securities on Nasdaq; the risk that the price of the Company’s securities may be volatile due to a variety of factors outside of the Company’s control; the risk that the Company never generates revenue; the risk that the Company fails to commercialize MTF on a cost-effective basis, on the expected timeline, or at all; the risk that the Company fails to achieve the objectives of the LM26 program; the risk that additional capital needed by the Company may not be raised on favorable terms, or at all, including as a result of the restrictions agreed to in connection with the private placement the Company closed on July 10, 2026; the risk that fusion energy does not gain public acceptance; the risk that the scientific and technical assumptions upon which MTF technology is based do not prove to be correct; the risk that our competitors develop viable fusion technology sooner than we do; the risk of supply chain disruptions; the risk that key technical material and service inputs may not be available when required, on reasonable terms or at all; the risk that we are unable to attract and retain qualified personnel with highly technical expertise; the risk that we are subject to negative publicity; the risk that our assessment of the total addressable market for fusion energy is incorrect; the risk of changes in the laws and regulations governing the Company’s research and development activities and in the regulation of fusion energy; the risk of fluctuations in currency markets; the risk that the Company is unable to complete and successfully integrate any future acquisitions; the risk of increased competition in the fusion industry; the risk of accidents, earthquakes, fires, floods, and other natural disasters; the risk that our information technology fails; the risk that our operating expenses are materially higher than forecast; the risk that we are unable to remediate material weaknesses in our internal controls or identify additional material weaknesses in the future; the risk that we are unable to adequately protect or enforce our intellectual property rights; the risk of third-party claims that we are infringing or violating another person’s intellectual property rights; the risk that our intellectual property applications are not granted; the risk of a cyber event or privacy breach resulting in an interruption in operations or financial loss; the risk that government reduces or delays funding of government programs in which we participate; the risk that future sales by existing shareholders could cause our stock price to decline; and the risk that we are unable to establish and maintain effective internal controls to produce accurate and timely public disclosure. 
  
These forward-looking statements are based on certain assumptions, including that none of the risks identified above materialize, that there are no unforeseen changes to economic and market conditions, and that no significant events occur outside the ordinary course of business. 
  
The foregoing list is not exhaustive, and there may be additional risks that the Company does not know or currently believes are immaterial. You should carefully consider the foregoing factors, any other factors discussed herein, and in the other filings by the Company with the U.S. Securities and Exchange Commission, including those described under the heading “Risk Factors.” The Company does not undertake to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required in accordance with applicable laws.
  
Investor Relations Contact:
You can contact General Fusion’s Investor Relations team by email at: investors@generalfusion.com.
  
If you are based in North America, you may also leave a toll-free voicemail at +1 (833) 717-1519. Callers outside North America can reach us at +1 (236) 253-6968. 
  
Media Relations Contact:
media@generalfusion.com
1-866-904-0995

Why Microcap AMFN Stock Soared Nearly 60% For Its Best Day Of The Year

Equity

American Fusion said it received the certification for its Texatron Fusion Engine Models last week and expects research and development testing to begin the week of July 27, subject to scheduling and personnel availability. 

General Fusion to Ring Nasdaq Opening Bell Today, July 17, 2026

General Fusion Becomes First Publicly Listed Fusion Company Begins trading on Nasdaq under the ticker symbol “GFUZ”

EXCLUSIVE: General Fusion CEO Greg Twinney Says Fusion's Safety Profile Could Unlock A Bigger Market Than Fission

General Fusion thinks nuclear fusion offers all the benefits of fission without the downsides.

The First Publicly Listed Fusion Stock Just Started Trading, and It Did Not Arrive Quietly

The First Publicly Listed Fusion Stock Just Started Trading, and It Did Not Arrive Quietly The First Publicly Listed Fusion Stock Just Started Trading, and It Did Not Arrive Quietly PR Newswire VANCOUVER, BC, July 13, 2026 General Fusion opens on the Nasdaq under GFUZ, backed by more than 200,000...

A 20-Year Fusion Bet Just Closed Its Business Combination, and a New Kind of Energy Stock Is About to Reach the Public Markets

A 20-Year Fusion Bet Just Closed Its Business Combination, and a New Kind of Energy Stock Is About to Reach the Public Markets A 20-Year Fusion Bet Just Closed Its Business Combination, and a New Kind of Energy Stock Is About to Reach the Public Markets PR Newswire VANCOUVER, British Columbia, July...

General Fusion Group Ltd. engages in the fusion industry, developing practical magnetized target fusion technology that is designed to address the key barriers to commercializing fusion. The company is headquartered in Richmond, Canada.

General Fusion Group Ltd.

Neutral Sentiment

President Trump has promised to issue a $5,000 "dividend" check to every adult American citizen if the Republican Party wins control of both the House and the Senate in the upcoming midterm elections, though the proposal would require congressional approval and follows his earlier $2,000 tariff-dividend plan, which stalled after the Supreme Court struck down much of his tariff authority. Do you think the $5,000 dividend check actually happens? Vote and explain your reasoning in the comments.

Trump has pledged a $5,000 &quot;dividend&quot; check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Stocktwits

Trump has pledged a $5,000 "dividend" check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Feed

News

Sentiment

Fundamentals

Info

GFUZ General Fusion Group Ltd.

Fundamentals

Latest GFUZ News